<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04893824</url>
  </required_header>
  <id_info>
    <org_study_id>P41-SP-0001</org_study_id>
    <nct_id>NCT04893824</nct_id>
  </id_info>
  <brief_title>Grappler® Interference Screw Post-Market Clinical Follow-Up Study</brief_title>
  <official_title>Grappler® Interference Screw Post-Market Clinical Follow-Up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paragon 28</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Paragon 28</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ambispective, multi-surgeon, single site, consecutive case series to determine the safety,&#xD;
      performance, and benefits of the Grappler(R) Interference Screw.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a ambispective, multi-surgeon, single site, consecutive case series. Data collection&#xD;
      will occur in two phases. Retrospective data collection will occur upon subject&#xD;
      identification, and data will be collected from the site's medical records for minimum of 50&#xD;
      subjects who have undergone soft tissue to bone fixation with the Grappler® Interference&#xD;
      Screw System. Data will be collected from the subjects' pre-op visits, intra-op visits, 7&#xD;
      week post-op follow-up visits (± 4 weeks), and 6 month post-op follow-up visits (± 4 weeks).&#xD;
      The subject must have adequate radiographic and medical records for the minimum follow up&#xD;
      requirement of 6 months. Prospective data collection will occur upon subject's provision of&#xD;
      written informed consent, and data will be collected from patient reported outcomes (PRO's).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 19, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of revisions</measure>
    <time_frame>6 Months Post-Op</time_frame>
    <description>Safety will be assessed by recording the incidence of revisions. The relationship of events will be attributed to either the implant or instrumentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>6 Months Post-Op</time_frame>
    <description>Safety will be assessed by recording the incidence of adverse events. The relationship of events will be attributed to either the implant or instrumentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>6 Months Post-Op</time_frame>
    <description>Safety will be assessed by recording the incidence of complications. The relationship of events will be attributed to either the implant or instrumentation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of recurrence of deformity</measure>
    <time_frame>7 Weeks Post-Op, 6 Months Post-Op</time_frame>
    <description>Safety as related to rate of recurrence of deformity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of implant failure</measure>
    <time_frame>Intra-Op, 7 Weeks Post-Op, 6 Months Post-Op</time_frame>
    <description>Safety as related to rate of implant failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of re-tear or re-rupture of fixated soft tissue</measure>
    <time_frame>7 Weeks Post-Op, 6 Months Post-Op</time_frame>
    <description>Safety as related to rate of re-tear or re-rupture of fixated soft tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of screw removal</measure>
    <time_frame>7 Weeks Post-Op, 6 Months Post-Op</time_frame>
    <description>Safety as related to rate of screw removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foot and Ankle Mobility Measure</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Device performance and benefits as related to Foot and Ankle Mobility Measure Activities of Daily Living (0-84) and sports (0-32) subscales. The higher the score, the higher the level of function, with 100% representing no dysfunction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Device performance and benefits as related to pain levels based on the Visual Analog Scale (range: 0 to 100; 0 = no pain; 100 = worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>6 months post-operative</time_frame>
    <description>Device performance and benefits as related to patient satisfaction (very satisfied, good, fair, not satisfied)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ankle Injuries</condition>
  <condition>Syndesmotic Injuries</condition>
  <condition>Ankle Inversion Sprain</condition>
  <condition>Deltoid Ankle Sprain</condition>
  <condition>Achilles Tendon Rupture</condition>
  <condition>Flexor Hallucis Longus on the Left</condition>
  <condition>Flexor Digitorum Longus on the Left</condition>
  <condition>Ankle Sprains</condition>
  <condition>Flexor Hallucis Longus on the Right</condition>
  <condition>Flexor Digitorum Longus on the Right</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Grappler® Interference Screw System</intervention_name>
    <description>Foot and/or ankle procedure involving soft tissue attachment to bone using the Grappler® Interference Screw System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigational population will include a minimum of 50 subjects who have undergone a&#xD;
        foot and/or ankle procedure that fulfill the eligibility criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The subject must have undergone a foot and/or ankle procedure involving soft tissue&#xD;
             attachment to bone using the Grappler® Interference Screw System and completed by one&#xD;
             of the designated investigators who are experienced in the use of such implants and&#xD;
             the required specialized surgical techniques&#xD;
&#xD;
          -  The subject must have adequate radiographic and medical records for the minimum&#xD;
             follow-up requirement of six months&#xD;
&#xD;
        For the Prospective Data Collection:&#xD;
&#xD;
        - The subject is willing to provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Jacy Legue</last_name>
    <role>Study Director</role>
    <affiliation>Paragon 28</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopedic Foot and Ankle</name>
      <address>
        <city>Worthington</city>
        <state>Ohio</state>
        <zip>43085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Sprains and Strains</mesh_term>
    <mesh_term>Ankle Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

